Connor, Clark & Lunn Investment Management Ltd. - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q2 2023$151,480
-54.7%
126,233
-52.5%
0.00%
-50.0%
Q1 2023$334,711
-77.0%
265,644
+118.6%
0.00%
-80.0%
Q3 2022$1,456,000
+203.3%
121,546
+111.9%
0.01%
+233.3%
Q2 2022$480,000
+22.1%
57,367
+26.8%
0.00%
+50.0%
Q1 2022$393,000
-24.0%
45,254
-1.0%
0.00%
-33.3%
Q4 2021$517,000
-11.6%
45,719
-1.7%
0.00%0.0%
Q3 2021$585,00046,5060.00%
Other shareholders
GOSSAMER BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,164,835$27,471,0005.62%
Kynam Capital Management, LP 1,832,704$15,908,0005.16%
Octagon Capital Advisors LP 2,563,138$22,248,0004.81%
Ally Bridge Group (NY) LLC 450,000$3,906,0002.90%
HHLR ADVISORS, LTD. 7,420,974$64,414,0001.34%
Palo Alto Investors LP 1,756,757$15,249,0001.18%
Boxer Capital, LLC 2,462,358$21,373,0001.10%
Ikarian Capital, LLC 775,315$6,730,0000.88%
Artal Group S.A. 2,358,968$20,476,0000.86%
Birchview Capital, LP 129,088$1,120,0000.81%
View complete list of GOSSAMER BIO INC shareholders